Wyeth Renal Cancer Drug Gets 'Fast Track' Status
472457
Wyeth said on Tuesday that U.S.  regulators will review on an accelerated basis its experimental  drug temsirolimus as a first line treatment for advanced renal  cell carcinoma.
535223
An experimental drug under development by Bristol-Myers Squibb is showing early promise in reversing the signs and symptoms of patients whose chronic myeloid leukemia failed to respond to Gleevec, which is considered the standard of treatment for the
253298
The drug company pushes on after the Enhance trials.
303304
Wyeth on Wednesday faced   accusations that one of its hormone replacement therapy (HRT)   drugs caused breast cancer in a 67-year-old woman as one of the   thousands of trials the drug maker is facing over the treatment   got underway.
131634
More than a quarter of patients with  advanced kidney cancer saw their tumors shrink after treatment  with GlaxoSmithKline Plc&#39;s pazopanib, a new pill designed to  rival Genentech&#39;s blockbuster drug Avastin, researchers said on  Saturday.
742628
A fast-acting pathway used by the drug tamoxifen to kill damaged breast cells before they become cancerous has been identified by scientists at Duke University.
227722
WEDNESDAY, March 7 (HealthDay News) -- Positron emission tomography (PET) imaging can identify an aggressive form of kidney cancer and may eliminate the need for biopsy in some patients, U.S. researchers report.
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
729663
German drugmaker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for the  prevention of bone tumors in breast cancer patients.
92266
Wyeth is seeking US approval in the next 18 months of seven new drugs that may ultimately generate more than $6 billion in annual revenue, chief executive Robert Essner told analysts.
564001
A drug being developed by Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some liver cancer patients and temporarily stabilized the
594161
Genzyme announces positive study results with a recently acquired drug.
321830
The FDA grants a speedy review for Millennium's lead drug.
537171
The kidney cancer pill Nexavar has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia or AML, U.S. researchers said on Tuesday.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
92836
THURSDAY, Aug. 19 (HealthDayNews) -- A new screening technique to search for genes that change patients' response to cancer drugs and other medications has been developed by scientists at Washington University Medical Center.
438501
Here's what a newly approved drug looks like.